Real-world use and effectiveness of patiromer among patients with heart failure at high risk of hyperkalaemia: insights from the CARE-HK in HF registry

Back

HFA Premium Access

Real-world use and effectiveness of patiromer among patients with heart failure at high risk of hyperkalaemia: insights from the CARE-HK in HF registry

Session: Diverse pharmacological progress in heart failure

Topic: Pharmacotherapy

Speaker: Doctor A. Sauer (Kansas City, US)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Andrew Sauer

St. Luke's Mid America Heart Institute, Kansas City (United States of America)

3 presentations

0 follower

5 more presentations in this session

Safety and efficacy of early initiation of sodium-glucose co-transporter inhibitors 2 in patients hospitalized for acute heart failure: a meta-analysis of randomized controlled trials

Speaker: Doctor R. Laborante (Rome, IT)

Sodium-glucose co-transporter-2 inhibitors: prognostic benefit in real-world, elderly, comorbid HFmrEF and HFpEF patients

Speaker: Mrs S. Valdivielso (Barcelona, ES)

Diuretic resistance and the efficacy of hydrochlorothiazide in acute decompensated heart failure: a post-hoc analysis of the CLOROTIC Trial

Speaker: Doctor A. Pandey (Dallas, US)

Impact of l-arginine supplementation on quality of life in patients with heart failure: a meta-analysis of randomized controlled trials

Speaker: Doctor A. Alvez (Quezon City, PH)

Serum digoxin concentrations in patients with heart failure: a post-hoc analysis of the BIOSTAT-CHF study

Speaker: Mr D. Baron (Groningen, NL)

Access the full session

Diverse pharmacological progress in heart failure

Speakers: Doctor A. Sauer, Doctor R. Laborante, Mrs S. Valdivielso, Doctor A. Pandey, Doctor A. Alvez...

Access

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources